Cargando…
Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design
Randomized controlled trials on drug safety and effectiveness are the foundation of medical evidence, but they may have limited generalizability and be unpowered to detect rare and long-term kidney outcomes. Observational studies in routine care data can complement and expand trial evidence on the u...
Autores principales: | Trevisan, Marco, Fu, Edouard L, Xu, Yang, Jager, Kitty, Zoccali, Carmine, Dekker, Friedo W, Carrero, Juan Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247736/ https://www.ncbi.nlm.nih.gov/pubmed/34221367 http://dx.doi.org/10.1093/ckj/sfaa244 |
Ejemplares similares
-
Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them
por: Fu, Edouard L, et al.
Publicado: (2020) -
A new series of advanced-level research methods papers
por: Jager, Kitty J, et al.
Publicado: (2020) -
The long-term benefits of early intensive therapy in chronic diseases—the legacy effect
por: Zoccali, Carmine, et al.
Publicado: (2023) -
An introduction to inverse probability of treatment weighting in observational research
por: Chesnaye, Nicholas C, et al.
Publicado: (2021) -
Translational research in nephrology: prognosis
por: Tripepi, Giovanni, et al.
Publicado: (2021)